SmartCatch

📍 Toulouse, France🗓 Founded 2016👥 20 employees💰 Last funded Jun 2021
Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was established in September 2016 and exploits an innovative technology of physical capture of circulating tumor cells. SmartCatch designs capture micro-devices that look like micro-fishnets. These products can be used for early diagnosis of cancer,personnalized therapeutic follow-up and pharmaceutical screening.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
France
1
Frequently asked questions
Who invested in SmartCatch?
SmartCatch has 1 investors on record on gritt.io, 1 mid-stage.
When did SmartCatch last raise funding?
The most recent investment in SmartCatch recorded on gritt.io was in June 2021.
When was SmartCatch founded?
SmartCatch was founded in 2016.
What industry is SmartCatch in?
SmartCatch operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is SmartCatch based?
SmartCatch is headquartered in Toulouse, France.